DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Abraxane (Paclitaxel) - Dehydration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dehydration (18)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Abraxane (Paclitaxel) where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: female, weighing 64.9 kg (142.8 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Vomiting, Gastrointestinal Haemorrhage, Nausea, Hyponatraemia, Hypokalaemia, Haemoglobin Decreased, Diarrhoea, Dehydration, Hypocalcaemia, Neutrophil Count Decreased, Blood Creatinine Increased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 177 milligram
    Start date: 2012-07-18
    End date: 2012-07-25

Abraxane
    Dosage: 80 microgram/sq. meter
    Start date: 2012-08-01

Abraxane
    Dosage: 177 milligram
    Indication: Breast Cancer
    Start date: 2012-06-13

Carboplatin
    Dosage: 675 milligram
    Indication: Breast Cancer
    Start date: 2012-06-13

Carboplatin
    Dosage: 675 milligram
    Start date: 2012-07-18

Herceptin
    Dosage: 139 milligram
    Start date: 2012-07-18

Herceptin
    Dosage: 139 milligram
    Indication: Breast Cancer
    Start date: 2012-06-13

Other drugs received by patient: Dexamethasone; Gabapentin; Ativan; Motrin; Ativan; Vicodin; Ativan; Ativan



Possible Abraxane side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient: 43 year old female, weighing 64.9 kg (142.8 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Vomiting, Nausea, Gastrointestinal Toxicity, Haemorrhoids, Haematemesis, Haemoglobin Decreased, Blood Potassium Decreased, NO Therapeutic Response, Diarrhoea Haemorrhagic, Dehydration, Clostridial Infection, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 177 mg
    Indication: Breast Cancer

Carboplatin
    Dosage: 675 mg
    Indication: Breast Cancer

Herceptin
    Dosage: 139 mg
    Indication: Breast Cancer

Other drugs received by patient: Dexamethasone; Ativan; Lomotil; Gabapentin; Ondansetron HCL; Vicodin; Pantoprazole



Possible Abraxane side effects in 43 year old female

Reported by a physician from United States on 2012-07-30

Patient: 43 year old female, weighing 121.0 kg (266.2 pounds)

Reactions: Vomiting, Dyspnoea, Nausea, Anaemia, Hypokalaemia, Diarrhoea, Hypophagia, Dehydration, NO Therapeutic Response, Fluid Intake Reduced

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 100mg/m2 weekly iv
    Indication: Breast Cancer
    Start date: 2012-03-26
    End date: 2012-05-11

Carboplatin
    Dosage: auc 4.5 qwk iv
    Indication: Breast Cancer
    Start date: 2012-03-26
    End date: 2012-05-04

Other drugs received by patient: Depakote; Metformin Hydrochloride; Compazine; Crestor; Detrol; Hydrochlorothiazide; Prozac; Motrin



Possible Abraxane side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: female

Reactions: Blood Calcium Decreased, Vomiting, Nausea, Diarrhoea, Dehydration, Blood Magnesium Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Progesterone



Possible Abraxane side effects in

Reported by a physician from United States on 2012-06-15

Patient:

Reactions: Hypotension, Transaminases Increased, Optic Neuropathy, Oesophagitis, Diarrhoea, Sepsis, Dehydration, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Abraxane

Erlotinib Hydrochloride

Gemcitabine



Possible Abraxane side effects in male

Reported by a physician from Canada on 2012-03-29

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Fatigue, Vomiting, Nausea, Dehydration, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 202 milligram
    Start date: 2011-09-28

Abraxane
    Dosage: 125 milligram/sq. meter
    Start date: 2011-09-01
    End date: 2011-09-07

Gemcitabine
    Dosage: 1000 milligram
    Start date: 2011-09-01
    End date: 2011-09-07

Gemcitabine
    Dosage: 1620 milligram
    Start date: 2011-09-28

Other drugs received by patient: Fentanyl; Dilaudid; Atenolol; Amlodipine; Maxeran



Possible Abraxane side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-16

Patient: male, weighing 109.0 kg (239.8 pounds)

Reactions: Dehydration, Upper Gastrointestinal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 125 milligram/sq. meter
    Start date: 2011-04-14
    End date: 2011-05-24

Gemzar
    Dosage: 1000 milligram/sq. meter
    Start date: 2011-04-14
    End date: 2011-05-24

Other drugs received by patient: Aloxi; Versed; Clonazepam; Ciprofloxacin Hydrochloride; Aspirin; Levemir; Novolog; Klonopin; Duragesic-100; Duragesic-100; Demerol; Ondansetron; Simethicone; Sodium Chloride; Phenergan; Sodium Chloride; Oxycodone HCL; Ducosate Sodium; Acetaminophen and Oxycodone HCL; Vitamin D; Decadron; Colace; Fentanyl-100; Ciprofloxacin Hydrochloride



Possible Abraxane side effects in 58 year old male

Reported by a consumer/non-health professional from United States on 2012-03-07

Patient: 58 year old male

Reactions: Dehydration, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-21

Patient: male, weighing 107.1 kg (235.6 pounds)

Reactions: Confusional State, Oral Pain, Dehydration, Failure To Thrive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 50 milligram/sq. meter
    Indication: Head and Neck Cancer
    Start date: 2011-06-20
    End date: 2011-08-01

Carboplatin
    Dosage: auc of 1.5
    Indication: Head and Neck Cancer
    Start date: 2011-06-20
    End date: 2011-08-01

Other drugs received by patient: Alkalol; Colace; Dilaudid; Ritalin; Nefazodone HCL; Reglan; MBL Mouthwash; Mirtazapine; Seroquel; Atenolol; Methadone HCL; Oxycodone HCL; Terazosin HCL; Lorazepam; Ondansetron; Oxycodone HCL; Ativan; Armodafinil; Senna; Serzone; Simvastatin



Possible Abraxane side effects in male

Reported by a physician from Canada on 2012-02-10

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Fatigue, Vomiting, Nausea, Dehydration, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 202 milligram/sq. meter
    Start date: 2011-09-28

Abraxane
    Dosage: 125 milligram/sq. meter
    Start date: 2011-09-01
    End date: 2011-09-07

Gemcitabine
    Dosage: 1000 milligram/sq. meter
    Start date: 2011-09-01
    End date: 2011-09-07

Gemcitabine
    Dosage: 1620 milligram/sq. meter
    Start date: 2011-09-28

Other drugs received by patient: Fentanyl Citrate; Dilaudid; Amlodipine; Maxeran; Atenolol



Possible Abraxane side effects in male

Reported by a physician from United States on 2012-02-01

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Dermatitis Acneiform, Stomatitis, Dehydration, Tachycardia, Enteritis Infectious, Femoral Hernia, Obstructive, Fall

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 20 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Cisplatin
    Dosage: 20 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Erbitux
    Dosage: 400 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Erbitux
    Dosage: 250 milligram/sq. meter
    Start date: 2011-07-05

Other drugs received by patient: Magnesium Sulfate; Potassium Chloride; Lovenox; Lovenox; Triple MIX (Benadryl, Maalox, Lidocaine); Veramyst; Dexamethasone; Regular Insulin; Famotidine; Magnesium Sulfate; Potassium Phosphates; Insulin; Ocean Spray; Phosnak; Klor-CON; Metoprolol Tartrate; Singulair; Ondansetron HCL; Magnesium Sulfate; Actiq; Prochlorperazine Maleate; Qualaquin; 0.9% NS; Potassium Chloride; Astepro; Metoprolol Tartrate; Domeboro; Calcium Gluconate; Famotidine; Magnesium Sulfate; Magnesium Sulfate; Genasal; 0.9% NS; Potassium Phosphates; Potassium Chloride; Magnesium Oxide; Metoprolol Tartrate; Ondansetron HCL; 0.9% NS; 0.9% NS; Morphine Sulfate; Rocephin; Magnesium Sulfate; Potassium Phosphates; Doxycycline; RED Blood Cells; Ativan; Metoprolol Tartrate; Benadryl; Calcium Gluconate; Potassium Chloride



Possible Abraxane side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13

Patient: 52 year old female, weighing 82.0 kg (180.4 pounds)

Reactions: Vomiting, Nausea, Chills, Fatigue, Dehydration, Thrombocytopenia, Leukopenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 185 mg; weekly; iv
    Indication: Breast Cancer
    Start date: 2011-10-12
    End date: 2012-01-04

Carboplatin
    Dosage: 170mg; weekly; iv
    Indication: Breast Cancer
    Start date: 2011-10-12
    End date: 2012-01-04

Other drugs received by patient: Oxycodone HCL; Compazine; Bevacizumab; Hydrochlorothiazide; Prilosec; Lisinopril; Metformin HCL; Ondansetron; Ativan; Decadron; Imodium



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-14

Patient: female, weighing 69.0 kg (151.8 pounds)

Reactions: Vomiting, Nausea, Dehydration, Pleural Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 125 milligram/sq. meter
    Start date: 2011-11-10
    End date: 2011-11-13

Gemcitabine
    Dosage: 1000 milligram/sq. meter
    Start date: 2011-11-10
    End date: 2011-11-13

Other drugs received by patient: Omeprazole; Fentanyl; Ondansetron Hydrochloride; Dulcolax; Acetaminophen and Hydrocodone Bitartrate; Ondansetron Hydrochloride



Possible Abraxane side effects in 64 year old female

Reported by a physician from United States on 2011-12-02

Patient: 64 year old female

Reactions: Haemoglobin Decreased, Weight Decreased, Diarrhoea, Oral Candidiasis, Hypotension, Dehydration, Neutropenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 186 milligram
    Indication: Breast Cancer
    Start date: 2011-06-28

Bevacizumab / Placebo
    Indication: Breast Cancer
    Start date: 2011-03-03
    End date: 2011-06-14

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-03
    End date: 2011-04-19

Doxorubicin HCL
    Dosage: 60 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-03
    End date: 2011-04-19

Neulasta
    Dosage: 6 milligram
    Indication: Breast Cancer
    Start date: 2011-03-03
    End date: 2011-04-20

Other drugs received by patient: Prbc; Hydration; Nystatin



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-18

Patient: female, weighing 69.0 kg (151.8 pounds)

Reactions: Vomiting, Nausea, Dehydration, Pleural Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 125 milligram/sq. meter
    Start date: 2011-11-10

Gemcitabine
    Dosage: 1000 milligram/sq. meter
    Start date: 2011-11-10

Other drugs received by patient: Fentanyl-100; Ondansetron Hydrochloride; Ondansetron Hydrochloride; Dulcolax; Acetaminophen and Hydrocodone Bitartrate; Omeprazole



Possible Abraxane side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-10

Patient: male, weighing 71.3 kg (156.8 pounds)

Reactions: Dehydration, Acute Respiratory Distress Syndrome, Neutropenia, Cerebral Haemorrhage, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Abraxane
    Indication: Bladder Cancer

Aspirin
    Dosage: 81 milligram
    Administration route: Oral

Other drugs received by patient: Platelets; RED Blood Cells



Possible Abraxane side effects in male

Reported by a physician from United States on 2011-11-01

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Small Intestinal Obstruction, Dermatitis Acneiform, Stomatitis, Dehydration, Tachycardia, Enteritis Infectious, Fall

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 20 milligram/sq. meter
    Start date: 2011-07-05
    End date: 2011-08-09

Cisplatin
    Dosage: 20 milligram/sq. meter
    Start date: 2011-07-05
    End date: 2011-08-09

Erbitux
    Dosage: 400 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Erbitux
    Dosage: 250 milligram/sq. meter
    Start date: 2011-07-05

Other drugs received by patient: Qualaquin; Rocephin; Magnesium Sulfate; RED Blood Cells; Actiq; Ativan; Klor-CON; 0.9% NS; 0.9% NS; Famotidine; Potassium Chloride; Potassium Chloride; Doxycycline; Metoprolol Tartrate; Calcium Gluconate; Magnesium Sulfate; Potassium Phosphates; Astepro; Triple MIX (Benadryl, Maalox, Lidocaine); Domeboro; Magnesium Sulfate; Magnesium Sulfate; Lovenox; Ocean Spray; Phosnak; Metoprolol Tartrate; Zofran; Dexamethasone; Genasal; Metoprolol Tartrate; Metoprolol Tartrate; Singulair; Veramyst; Potassium Phosphates; Potassium Chloride; Magnesium Oxide; Benadryl; Regular Insulin; Calcium Gluconate; Potassium Phosphates; Insulin; Prochlorperazine Maleate; Zofran; 0.9% NS; 0.9% NS; Morphine Sulfate; Famotidine; Magnesium Sulfate; Magnesium Sulfate; Potassium Chloride; Lovenox



Possible Abraxane side effects in male

Reported by a physician from United States on 2011-10-20

Patient: male, weighing 65.9 kg (145.0 pounds)

Reactions: Dermatitis Acneiform, Stomatitis, Tachycardia, Dehydration, Femoral Hernia, Obstructive, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 20 milligram/sq. meter
    Start date: 2011-07-05
    End date: 2011-08-09

Cisplatin
    Dosage: 20 milligram/sq. meter
    Start date: 2011-07-05
    End date: 2011-08-09

Erbitux
    Dosage: 250 milligram/sq. meter
    Start date: 2011-07-05

Erbitux
    Dosage: 400 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Other drugs received by patient: 0.9% NS; Benadryl; Calcium Gluconate; Potassium Chloride; Actiq; Astepro; Qualaquin; 0.9% NS; Morphine Sulfate; Regular Insulin; Potassium Chloride; Metoprolol Tartrate; Domeboro; Potassium Phosphates; Veramyst; Magnesium Sulfate; Klor-CON; Famotidine; Ativan; Prochlorperazine Maleate; 0.9% NS; Rocephin; Calcium Gluconate; Famotidine; Magnesium Sulfate; Potassium Phosphates; 0.9% NS; Magnesium Oxide; Singulair; Triple MIX (Benadryl, Maalox, Lidocaine); Zofran; Zofran; Dexamethasone; Magnesium Sulfate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017